Genome alteration-matched treatment of breast cancer to target amplification of human epidermal growth factor receptor 2 gene (Erb-B2 receptor tyrosine kinase 2, ERBB2 also known as HER2) is an example of a successful gene-targeted therapy2. Here, ERBB2 is linked to breast carcinoma.